We are live on ! Find out more
AAF

Andra AP-fonden Portfolio holdings

AUM $8.39B
1-Year Est. Return 21.19%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
10 Year Est. Return
AUM
$1.89B
AUM Growth
+$192M
Cap. Flow
-$8.44M
Cap. Flow %
-0.45%
Top 10 Hldgs %
11.69%
Holding
260
New
Increased
128
Reduced
97
Closed
31

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$10.7M
3
MRK icon
Merck
MRK
+$9.96M
4
MCK icon
McKesson
MCK
+$8.37M
5
CMCSA icon
Comcast
CMCSA
+$8.14M

Sector Composition

Rank Sector Weight
1 Technology 21.43%
2 Healthcare 19.25%
3 Financials 13.87%
4 Communication Services 10.49%
5 Consumer Discretionary 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSA icon
51
Public Storage
PSA
$61.1B
$11.7M 0.62%
38,200
+17,200
+82% +$4.56M
XYL icon
52
Xylem
XYL
$28.2B
$11.6M 0.61%
101,400
+18,800
+23% +$1.88M
NWSA icon
53
News Corp Class A
NWSA
$16.1B
$11.6M 0.61%
472,100
+12,100
+3% +$263K
IQV icon
54
IQVIA
IQV
$38.3B
$11.6M 0.61%
50,000
-1,200
-2% -$246K
WDAY icon
55
Workday
WDAY
$42B
$11.5M 0.61%
41,700
-1,700
-4% -$405K
NFLX icon
56
Netflix
NFLX
$307B
$11.2M 0.6%
231,000
-37,000
-14% -$1.62M
DHI icon
57
D.R. Horton
DHI
$40.8B
$11.2M 0.59%
73,500
-12,800
-15% -$1.58M
ELS icon
58
Equity Lifestyle Properties
ELS
$12.5B
$11.1M 0.59%
156,900
+100
+0.1% +$6.81K
NTAP icon
59
NetApp
NTAP
$37.6B
$10.8M 0.57%
122,000
+4,700
+4% +$378K
SSNC icon
60
SS&C Technologies
SSNC
$18.7B
$10.7M 0.56%
174,400
-28,000
-14% -$1.53M
ACN icon
61
Accenture
ACN
$105B
$10.5M 0.56%
30,008
+200
+0.7% +$64.5K
PNR icon
62
Pentair
PNR
$11.2B
$10.3M 0.55%
142,200
+4,000
+3% +$258K
FNF icon
63
Fidelity National Financial
FNF
$14.1B
$10.3M 0.54%
201,200
+28,000
+16% +$1.22M
EXPE icon
64
Expedia Group
EXPE
$36.8B
$10.2M 0.54%
66,900
+6,500
+11% +$796K
CRM icon
65
Salesforce
CRM
$153B
$10M 0.53%
37,998
+2,200
+6% +$498K
SBAC icon
66
SBA Communications
SBAC
$19.4B
$9.72M 0.51%
38,300
-12,100
-24% -$2.72M
NBIX icon
67
Neurocrine Biosciences
NBIX
$16.2B
$9.59M 0.51%
72,800
+18,200
+33% +$2.09M
MSCI icon
68
MSCI
MSCI
$41.2B
$9.56M 0.51%
16,900
+200
+1% +$103K
EG icon
69
Everest Group
EG
$14.2B
$9.55M 0.51%
27,000
+3,400
+14% +$1.32M
VTR icon
70
Ventas
VTR
$47.3B
$9.41M 0.5%
188,800
+24,700
+15% +$1.11M
ETN icon
71
Eaton
ETN
$174B
$9.39M 0.5%
39,000
+1,700
+5% +$375K
VRTX icon
72
Vertex Pharmaceuticals
VRTX
$123B
$9.36M 0.5%
23,000
+5,800
+34% +$2.14M
MRNA icon
73
Moderna
MRNA
$21.5B
$9.23M 0.49%
92,800
+33,800
+57% +$2.84M
CB icon
74
Chubb
CB
$137B
$9.22M 0.49%
40,800
+3,600
+10% +$787K
CCI icon
75
Crown Castle
CCI
$32.7B
$9.12M 0.48%
79,200
+5,100
+7% +$522K

Similar funds

Andra AP-fonden's Q4 2023 Portfolio in Review

As of Q4 2023, Andra AP-fonden held 260 positions worth $1.89B, up 11% from $1.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Andra AP-fonden's Q4 2023 filing shows 128 increased, 97 reduced and 31 closed positions. The largest sale was Bunge Global, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Andra AP-fonden added most to AbbVie in Q4 2023, an estimated $11.7M increase.
  • Andra AP-fonden's biggest Q4 2023 reduction was HP, cutting an estimated $5.37M.
  • Andra AP-fonden fully exited Bunge Global in Q4 2023, selling an estimated $16.4M.
  • Andra AP-fonden's ten largest holdings make up 12% of its $1.89B portfolio in Q4 2023.
  • Andra AP-fonden opened 0 new positions and closed 31 in Q4 2023.
  • Andra AP-fonden's portfolio value rose 11% quarter-over-quarter to $1.89B.

Based on Andra AP-fonden's 13F filing for Q4 2023, filed 15 Feb 2024.